Real-World Evidence for Neonatal Drug Development: Challenges and Opportunities

被引:2
|
作者
Singh, Kanwaljit [1 ]
Concato, John [2 ,3 ]
Davis, Jonathan M. [4 ,5 ]
机构
[1] Crit Path Inst, Pediat Programs, Tucson, AZ USA
[2] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] Yale Univ, Dept Med, New Haven, CT USA
[4] Tufts Med Ctr, Dept Pediat, 800 Washington St, Boston, MA 02111 USA
[5] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
来源
JOURNAL OF PEDIATRICS | 2024年 / 265卷
关键词
D O I
10.1016/j.jpeds.2023.113806
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Real-world evidence and regulatory drug approval
    Raphael, Michael J.
    Gyawali, Bishal
    Booth, Christopher M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (05) : 271 - 272
  • [22] Real-world evidence and regulatory drug approval
    Michael J. Raphael
    Bishal Gyawali
    Christopher M. Booth
    Nature Reviews Clinical Oncology, 2020, 17 : 271 - 272
  • [23] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Prioty Islam
    Anthony R. Mato
    Current Hematologic Malignancy Reports, 2020, 15 : 254 - 260
  • [24] LEVERAGING HOSPITAL-BASED EMR SYSTEMS FOR REAL-WORLD EVIDENCE GENERATION: OPPORTUNITIES AND CHALLENGES
    Stein, D.
    Carroll, R.
    Dhalwani, N.
    Ramagopalan, S.
    VALUE IN HEALTH, 2018, 21 : S369 - S370
  • [25] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Islam, Prioty
    Mato, Anthony R.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (04) : 254 - 260
  • [26] Opportunities and challenges in using real-world data for health care
    Rudrapatna, Vivek A.
    Butte, Atul J.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (02): : 565 - 574
  • [27] Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
    Katsutoshi Hiramatsu
    Annabel Barrett
    Yasuhiko Miyata
    Drugs - Real World Outcomes, 2021, 8 : 459 - 480
  • [28] Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
    Hiramatsu, Katsutoshi
    Barrett, Annabel
    Miyata, Yasuhiko
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (04) : 459 - 480
  • [29] The role of early-phase trials and real-world evidence in drug development
    Harriette G. C. Van Spall
    Arnaud Bastien
    Bernard Gersh
    Barry Greenberg
    Reza Mohebi
    James Min
    Karsten Strauss
    Steffen Thirstrup
    Faiez Zannad
    Nature Cardiovascular Research, 2024, 3 : 110 - 117
  • [30] REAL-WORLD EVIDENCE GENERATION IN JAPAN - USES AND CHALLENGES
    Graham, S.
    Laurent, T.
    Simeone, J.
    Kuwatsuru, R.
    Hirano, T.
    Phillips, R.
    Isomura, T.
    VALUE IN HEALTH, 2021, 24 : S194 - S194